血府逐瘀胶囊对重度血瘀证患者经皮冠状动脉介入治疗术后氯吡格雷抵抗的调节作用

黄瑾; 李璐奕; 祁炜罡; 黄瑛; 曾颖; 唐帆

doi:10.3969/j.issn.1006-0111.2018.06.012

血府逐瘀胶囊对重度血瘀证患者经皮冠状动脉介入治疗术后氯吡格雷抵抗的调节作用

doi: 10.3969/j.issn.1006-0111.2018.06.012

1.
上海中医药大学附属岳阳中西医结合医院药学部, 上海 200437;上海市浦东新区人民医院药剂科, 上海 201299
2.
上海市浦东新区人民医院药剂科, 上海 201299
3.
上海市浦东新区人民医院心内科, 上海 201299

基金项目: 浦东新区卫生系统学科带头人培养计划（PWRd-2014-11）；浦东新区示范中药药剂学科（示范中药房）建设项目（PDZYXK-2-2013003）

Regulating effect of Xuefuzhuyu capsule on clopidogrel resistance in patients with severe blood stasis syndrome after PCI operation

1.
Department of Pharmacy, Yueyang Hospital of Integrated Traditional Chinese and Western medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China;Department of Pharmacy, Pudong New Aera People's Hospital, Shanghai 201299, China
2.
Department of Pharmacy, Pudong New Aera People's Hospital, Shanghai 201299, China
3.
Department of Cardiology, Pudong New Aera People's Hospital, Shanghai 201299, China

摘要: 目的观察血府逐瘀胶囊联合氯吡格雷治疗氯吡格雷抵抗患者的效果，评价其改善氯吡格雷抵抗作用的效果。方法经皮冠状动脉介入治疗（PCI）术后氯吡格雷抵抗患者80人，随机分组，分别给予3种药物治疗方案：A组用国产氯吡格雷（泰嘉）加用血府逐瘀胶囊；B组使用进口氯吡格雷（波立维）；C组用国产氯吡格雷（泰嘉）加用西洛他唑，连续3个月，采用血栓弹力图法检测干预后血小板抑制率。并随访患者半年，观察临床不良事件的发生率。结果治疗3个月后，各组抑制率均有所提高，且均有显著差异（P<0.05）。A组对血小板抑制的有效率达40%，优于C组（33.33%），与B组相当（40.74%）。对阿司匹林、氯吡格雷均不敏感的患者换用进口波立维对提高血小板抑制效果更佳；仅对氯吡格雷不敏感的患者加用血府逐瘀胶囊对血小板抑制有协同作用。随访半年后发现，联合使用血府逐瘀胶囊的时间延长可能会增强血小板抑制的效果，但并不增加出血及凝血功能异常等风险。结论血府逐瘀胶囊对提高血小板抑制率有一定的作用，同时对出血风险影响较小。
- 血府逐瘀胶囊 /
- 血瘀证 /
- 氯吡格雷抵抗 /
- 冠状动脉粥样硬化
Abstract: Objective To observe and evaluate the regulating effect of Xuefuzhuyu capsule combined with clopidogrel on clopidogrel resistance. Methods After PCI operation, 80 patients with clopidogrel resistance were randomly divided into three different treatments,A:clopidogrel (Tai Jia) combined with Xuefuzhuyu capsule; B:clopidogrel (Plavix); C:clopidogrel (Tai Jia) combined with cilostazol.)After three months of continuous medication, and the inhibition rate of platelet aggregation was detected by thromboela-stogram(TEG).The patients were followed up for half a year to observe the incidence of adverse events. Results After three months of treatment, the inhibition rates of the three groups were improved(P<0.05).The effective rate of platelet inhibition in group A was 40% (10/25), which was higher to group C (33.33%), and which was equivalent to group B (40.74%). The effect of platelet aggregation inhibition was better in patients who were not sensitive to aspirin and clopidogrel and then with imported Plavix. And the treatment group of clopidogrel combined with Xuefuzhuyu capsule had a synergistic effect on platelet aggregation inhibition for clopidogrel insensitive patients. After six months' follow-up, it was found that the platelet inhibition was enhanced but the bleeding risk and abnormal coagulation function was not increased after prolonged using of Xuefuzhuyu capsule. Conclusion Xuefuzhuyu capsule had a certain effect on improving the inhibition rate of platelet aggregation, which had little effect on the risk of bleeding.
- Xuefuzhuyu capsule /
- blood stasis syndrome /
- clopidogrel resistance /
- coronary atherosclerosis

[1]	VLACHOJANNIS GJ, DIMITROPOULOS G, ALEXOPOULOS D.Clopidogrel resistance:current aspects and future directions[J]. Hellenic J Cardiol,2011,52(3):236-245.
[2]	余长永,张勇,邹建军,等.氯吡格雷抵抗原因及对策的研究进展[J].中国临床药理学与治疗学,2009,14(10):1168-1173.
[3]	陈慧,严威,吴小盈,等. 血瘀证CYP2C19基因多态性与氯吡格雷抵抗和PCI术预后的关系[J]. 中国中西医结合杂志,2010,30(12):1245-1249.
[4]	张文将,邓冰湘. 血府逐瘀汤抗动脉血栓形成及其作用机制的研究进展[J]. 湖南中医药大学学报,2013,33(4):102-104.
[5]	王阶,陈可冀,翁维良,等. 血瘀证诊断标准的研究[J]. 中西医结合杂志,1988,8(10):585-589.
[6]	陈可冀, 史载祥. 实用血瘀证学[M]. 北京:人民卫生出版社,1999:17-23.
[7]	陈伯钧,潘宗奇,苏学旭,等.冠心病介入治疗前后中医证型变化的研究[J].中国中西医结合杂志,2007,27(8):689-691.
[8]	褚福永,王阶,孙晓伟,等. 血府逐瘀胶囊改善不稳定型心绞痛介入术后血瘀证患者近期生活质量的随机双盲对照试验[J]. 中西医结合学报,2009,7(8):729-735.
[9]	涂金生,黄春兰.氯吡格雷对非ST段抬高冠脉综合征患者炎性因子及预后的影响[J].临床合理用药杂志,2015,8(3):84-85.

[1]	张修平, 田家盛, 王道鑫, 李佳鑫, 王品, 缪朝玉. MT-1207对血糖、血脂和动脉粥样硬化的作用 . 药学实践与服务, 2024, 42(): 1-8. doi: 10.12206/j.issn.2097-2024.202306011
[2]	王亚娟, 赵燕, 李维亮, 余爱荣. 缺血性脑卒中患者发生氯吡格雷抵抗的危险因素分析 . 药学实践与服务, 2024, 42(1): 32-37. doi: 10.12206/j.issn.2097-2024.202209054
[3]	王智聪, 谢彬, 袁星, 徐希科, 柳润辉. 基于网络药理学探讨麝香保心丸治疗动脉粥样硬化作用机制 . 药学实践与服务, 2023, 41(5): 296-301. doi: 10.12206/j.issn.2097-2024.202112001
[4]	王道鑫, 张添光, 缪朝玉. 血管内皮细胞线粒体氧化应激与动脉粥样硬化 . 药学实践与服务, 2023, 41(6): 329-334, 392. doi: 10.12206/j.issn.2097-2024.202205116
[5]	谢彬, 袁星, 徐希科, 柳润辉. 中药复方抗动脉粥样硬化作用机制的研究进展 . 药学实践与服务, 2021, 39(4): 295-298, 304. doi: 10.12206/j.issn.1006-0111.202103001
[6]	王品, 齐齐, 郑斯莉, 徐浩展, 缪朝玉. 动脉粥样硬化高脂饲料对小鼠糖脂水平的作用研究 . 药学实践与服务, 2021, 39(2): 121-125. doi: 10.12206/j.issn.1006-0111.202012002
[7]	邢心睿, 曹奇, 陈思, 朱臻宇. 基于UHPLC-Q-TOF/MS技术对扶正化瘀胶囊入血成分的快速鉴别 . 药学实践与服务, 2020, 38(3): 250-254, 267. doi: 10.12206/j.issn.1006-0111.201906027
[8]	钱俞君, 秦春霞, 孙莉莉, 丁华敏, 李铁军. 建立以HIF-1α为靶标的高通量筛选防治动脉粥样硬化先导化合物的细胞模型 . 药学实践与服务, 2019, 37(1): 27-31. doi: 10.3969/j.issn.1006-0111.2019.01.007
[9]	胡乔乔, 何佳. 不同剂量氯吡格雷对脑梗死患者神经功能的影响 . 药学实践与服务, 2017, 35(5): 449-452. doi: 10.3969/j.issn.1006-0111.2017.05.016
[10]	杨东, 毕建云, 郭艳伟, 张震宇. 正交试验优选逐瘀止痛凝胶膏剂的水提工艺研究 . 药学实践与服务, 2017, 35(2): 146-149. doi: 10.3969/j.issn.1006-0111.2017.02.012
[11]	干润, 霍炎, 黄金路, 杨全军, 郭澄. 孤儿核受体NR4A1与动脉粥样硬化的研究进展 . 药学实践与服务, 2016, 34(4): 292-296. doi: 10.3969/j.issn.1006-0111.2016.04.002
[12]	黄健, 戴亦晖, 郭尧注. 氯吡格雷不良反应文献分析 . 药学实践与服务, 2014, 32(1): 74-75.
[13]	毛峻琴, 侯中海, 陈大贵, 张文. 贻贝多糖MA对实验性动脉粥样硬化兔的作用 . 药学实践与服务, 2014, 32(1): 27-30. doi: 10.3969/j.issn.1006-0111.2014.01.007
[14]	刘佃花, 张恩晖, 刘冲, 范博士, 蔡国君. 烟碱致动脉粥样硬化的N胆碱受体信号通路 . 药学实践与服务, 2014, 32(2): 81-84. doi: 10.3969/j.issn.1006-0111.2014.02.001
[15]	郝少君, 吕宏迪, 李军, 苏峰, 张正臣. 心脑宁片对大鼠血瘀模型的影响 . 药学实践与服务, 2014, 32(5): 360-361,388. doi: 10.3969/j.issn.1006-0111.2014.05.012
[16]	陈巧玲, 蔡宝祥. 他汀类药物防治动脉粥样硬化作用研究进展 . 药学实践与服务, 2006, (6): 321-324.
[17]	张旭静, 孔建龙, 黄久仪, 王桂清. 中药抗动脉粥样硬化作用研究进展 . 药学实践与服务, 2004, (6): 321-323.
[18]	陈军, 方芸, 刁雨辉, 周菊萍. 三种方法测定逐瘀扶正胶囊中蒽醌类成分的含量 . 药学实践与服务, 2003, (5): 289-291.
[19]	李文杰. 少腹逐瘀胶囊致剥脱性皮炎1例 . 药学实践与服务, 2002, (4): 256-256.
[20]	陈军, 方芸, 刁雨辉. 比色法测定逐瘀扶正胶囊中蒽醌类成分的含量 . 药学实践与服务, 2002, (5): 297-300.

点击查看大图

计量

文章访问数: 2403
HTML全文浏览量: 271
PDF下载量: 374
被引次数: 0

姓名
邮箱
手机号码
标题
留言内容
验证码

留言板

血府逐瘀胶囊对重度血瘀证患者经皮冠状动脉介入治疗术后氯吡格雷抵抗的调节作用

doi: 10.3969/j.issn.1006-0111.2018.06.012

Regulating effect of Xuefuzhuyu capsule on clopidogrel resistance in patients with severe blood stasis syndrome after PCI operation

计量

血府逐瘀胶囊对重度血瘀证患者经皮冠状动脉介入治疗术后氯吡格雷抵抗的调节作用

doi: 10.3969/j.issn.1006-0111.2018.06.012

1. 上海中医药大学附属岳阳中西医结合医院药学部, 上海 200437;上海市浦东新区人民医院药剂科, 上海 201299

2. 上海市浦东新区人民医院药剂科, 上海 201299

3. 上海市浦东新区人民医院心内科, 上海 201299

English Abstract

Regulating effect of Xuefuzhuyu capsule on clopidogrel resistance in patients with severe blood stasis syndrome after PCI operation

全文HTML

目录

留言板

血府逐瘀胶囊对重度血瘀证患者经皮冠状动脉介入治疗术后氯吡格雷抵抗的调节作用

doi: 10.3969/j.issn.1006-0111.2018.06.012

Regulating effect of Xuefuzhuyu capsule on clopidogrel resistance in patients with severe blood stasis syndrome after PCI operation

计量

出版历程

血府逐瘀胶囊对重度血瘀证患者经皮冠状动脉介入治疗术后氯吡格雷抵抗的调节作用

doi: 10.3969/j.issn.1006-0111.2018.06.012

1. 上海中医药大学附属岳阳中西医结合医院药学部, 上海 200437;上海市浦东新区人民医院药剂科, 上海 201299 2. 上海市浦东新区人民医院药剂科, 上海 201299 3. 上海市浦东新区人民医院心内科, 上海 201299

English Abstract

Regulating effect of Xuefuzhuyu capsule on clopidogrel resistance in patients with severe blood stasis syndrome after PCI operation

全文HTML

目录

1. 上海中医药大学附属岳阳中西医结合医院药学部, 上海 200437;上海市浦东新区人民医院药剂科, 上海 201299

2. 上海市浦东新区人民医院药剂科, 上海 201299

3. 上海市浦东新区人民医院心内科, 上海 201299